MEASUREMENT AND IMPACT have been identified for inclusion in the VCCC’s own consultation process. Scoping is underway to inform Metrics for Clinical Trial Participation the feasibility and collection of potential metrics. While all stakeholders support improvement Next steps will test and validate the feasibility of of the cancer clinical trials system, it is less clear collecting the agreed metrics and address their how to achieve this or how to know when it has potential to create perverse incentives. been achieved. Improvements in participation, impact and innovation Clinical trials sites within the in clinical trials cannot be demonstrated unless new alliance represent seven organisations metrics are developed and agreed. employing over 150 Good Clinical This program is working to develop positive, robust Practice-accredited clinical trial staff. metrics that not only measure system change, but can VCCC alliance partner sites contribute be used as evidence and levers for improvement of the clinical trial system, particularly to drive the system- to more than 70 per cent of oncology wide cultural changes that will be required to achieve clinical trial participation in Victoria. lasting outcomes. Under this program the VCCC contributed to the Victorian Government round table on clinical trial metrics to help define the value of clinical trials. Key stakeholders within and beyond the VCCC 56